TheChineTime

Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up - Fierce Pharma

2026-02-27 - 15:03

Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up Fierce Pharma

Share this post: